ARCHIVES

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

This article is from The Cancer Letter archive.

Vol. 33 No. 13 | April 6, 2007

Download PDF Visit The Full Archive

Related Articles

GAO Finds Little Wrong With Drug Testing Program, But Offers Some Suggestions Anyways

July 1, 1983

DCCR Cancer Information Systems Program Renewed For Three More Years; Two Dropped, Two Added

September 1, 1978

FDA Approves Lymphoseek For Imaging Lymph Nodes

March 29, 2013

Obey Accuses Industry Of Blocking Control Of Carcinogens

November 10, 1978

In Brief: Fredrickson Okays NCI Reorganization, Plan At Hew; Miller Leave International Affairs Job

February 8, 1980

Nancy Davidson Named Director Of UPCI, Succeeding Herberman.

November 21, 2008